Topical Linalool and Tea Tree Oil Formulation for Ocular Infection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antibacterial preparations for eye and eyelid hygiene are either ineffective against pathogenic bacteria like Pseudomonas aeruginosa and Staphylococcus aureus or cause clinically significant conditions, such as irritation, due to their toxicity.
Innovation Solution
A topical preparation containing linalool and tea tree oil, combined with a membrane permeabilizer like Tris-EDTA, is developed to provide bactericidal activity against both gram-negative and gram-positive bacteria without causing significant eye irritation, formulated in concentrations effective for clinically relevant exposure times.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibacterial soaps and cleansers (Triclocarban, Triclosan, Benzalkonium Chloride, ethyl alcohol) are used, then bactericidal activity is achieved, but eye irritation and toxicity occur
Solution Approach 1:
The patent extracts and eliminates the toxic components (Triclocarban, Triclosan, Benzalkonium Chloride, ethyl alcohol) from conventional antibacterial formulations, replacing them with safer alternatives that maintain bactericidal activity without causing eye irritation
Solution Approach 2:
The patent changes the chemical parameters of the antibacterial agents by using linalool (0.7-1.5%) and tea tree oil (0.0125-0.050%) at optimized concentrations, combined with Tris-EDTA buffer system, to achieve effective bactericidal activity while maintaining ocular safety
2Reliability
If tea tree oil is used at high concentrations to achieve bactericidal activity, then antibacterial effect is improved, but eye irritation increases
Solution Approach 1:
The patent optimizes the concentration parameter of tea tree oil to 0.0125-0.050%, which is sufficient for bactericidal activity against S. aureus and P. aeruginosa while remaining below the threshold for eye irritation, demonstrating precise parameter control
Solution Approach 2:
The patent creates a composite formulation combining linalool (0.7-1.5%), tea tree oil (0.0125-0.050%), and Tris-EDTA buffer system, where each component contributes to overall bactericidal activity while the combination maintains safety profile
3Ease of operation
If conventional eyelid hygiene products (baby shampoo) are used, then ease of operation is improved, but antibacterial effectiveness is insufficient
Solution Approach 1:
The patent develops a composite ophthalmic formulation combining linalool, tea tree oil, and Tris-EDTA buffer that maintains the ease of topical application similar to conventional products while achieving proven bactericidal activity against pathogenic bacteria
Solution Approach 2:
The patent changes the active ingredient parameters from mild surfactants (baby shampoo) to optimized concentrations of linalool (0.7-1.5%) and tea tree oil (0.0125-0.050%), transforming the product from merely cleansing to actively bactericidal while remaining safe for ocular use
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The preparation achieves at least a 1 log reduction in colony-forming units of target bacteria within one minute of exposure, effectively treating or preventing infections like blepharitis, dry eye, and conjunctivitis without causing eye irritation.
Implementation Method 1
A topical preparation containing linalool and tea tree oil, combined with a membrane permeabilizer like Tris-EDTA, is developed to provide bactericidal activity
Implementation Method 2
combined with a membrane permeabilizer like Tris-EDTA
Data Source
AI summary
The instant invention provides methods and compositions for the treatment of infection or infectious colonization of the eyelid and/or ocular surface for the treatment and prevention of ocular disorders and eyelid disorders.